NRX Pharmaceuticals, Inc.
For the period ended Oct 30, 2026. Filed Nov 2, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 30, 2026 · Filed Nov 2, 2026
Use the contents to explore the available documents and sections.
NRXP$2.38+4.8%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · References
References
| 1. | U.S. Food and Drug Administration. (2019). Safety and effectiveness of consumer antiseptic rubs; topical antimicrobial drug products for over-the-counter human use. Federal Register, 84(71), 14847–14864. |
| 2. | U.S. Food and Drug Administration. (n.d.). Inactive ingredient search for approved drug products: Benzethonium chloride. Retrieved October 29, 2026, from https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm |
| 3. | https://www.regulations.gov/document/FDA-2025-P-3577-0004 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.